Brian J. Lynch

Insider Reports History

Entity
Individual
Location
480 Morris Road, Blue Bell, PA
Signature
/s/ Brian J. Lynch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian J. Lynch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Common Stock 17.7K $4.32M $243.92 Jan 23, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Market Stock Unit 3.64K $888K $243.92 Jan 23, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Common Stock 530 $129K $243.92 Jan 23, 2024 In IRA
MADRIGAL PHARMACEUTICALS, INC. SVP and General Counsel Stock Option (Right to Buy) 5.48K Jan 23, 2024 Direct

Insider Reports Filed by Brian J. Lynch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 23, 2024 3 $0 4 Jan 25, 2024 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2024 1 -$231K 4 Jan 18, 2024 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Dec 4, 2023 9 -$388K 4 Dec 6, 2023 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 29, 2023 9 -$894K 4 Dec 1, 2023 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2023 1 $0 4 Jan 18, 2023 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 3, 2023 12 -$2.48M 4 Jan 6, 2023 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Dec 23, 2022 16 -$1.28M 4 Dec 28, 2022 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Aug 10, 2022 1 $0 4 Aug 12, 2022 SVP and General Counsel
MDGL MADRIGAL PHARMACEUTICALS, INC. Feb 22, 2022 1 $0 4 Feb 24, 2022 SVP and General Councel